EMCOR names Pat Roche to Board; RSU grant on Oct 27, 2025

Rhea-AI Filing Summary

EMCOR Group, Inc. (EME) appointed Pat Roche to its Board of Directors, effective October 27, 2025. On the effective date, Mr. Roche received 158 restricted stock units, a prorated director grant with a market value of $119,266.30 based on the closing price that day.

He will be compensated under EMCOR’s standard non‑employee director policy, and entered into the company’s customary indemnification agreement. The company furnished a press release announcing the appointment on October 29, 2025 as Exhibit 99.1.

8-K Event Classification

3 items: 5.02, 7.01, 9.01

3 items

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance

Key personnel changes including departures, elections, or appointments of directors and executive officers.

Item 7.01 Regulation FD Disclosure Disclosure

Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, and exhibit attachments filed with this report.

Understanding 8-K Material Events →

0000105634false00001056342025-10-272025-10-27

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of report (Date of earliest event reported): October 27, 2025

EMCOR Group, Inc.

(Exact Name of Registrant as Specified in Its Charter)

Delaware

1-8267

11-2125338

(State or Other Jurisdiction of Incorporation)

(Commission File Number)

(I.R.S. Employer Identification No.)

301 Merritt Seven
Norwalk,			Connecticut						06851-1092
(Address of Principal Executive Offices)									(Zip Code)

(203)			849-7800
(Registrant’s Telephone Number, Including Area Code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐			Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol

Name of each exchange on which registered

Common Stock

EME

New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On October 27, 2025, the Board of Directors (the “Board”) of EMCOR Group, Inc. (the “Company”) elected Pat Roche to the Board, effective as of October 27, 2025 (the “Effective Date”).

On the Effective Date, Mr. Roche was awarded 158 restricted stock units, representing a prorated amount under the Company’s Director Award Program, with a market value of $119,266.30 based on the closing price of the Company’s common stock on the Effective Date. Such restricted stock units were issued pursuant to a Restricted Stock Unit Award Agreement, substantially similar to the Company’s standard form of Director Restricted Stock Unit Agreement, which was filed as Exhibit 10(k)(k) to the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2012, and is incorporated herein by reference. Mr. Roche will be compensated as a director in accordance with the Company’s compensation policy for non-employee directors as described in the Company’s Proxy Statement on Schedule 14A for its 2025 Annual Meeting of Stockholders. Mr. Roche and the Company also entered into an indemnification agreement, substantially similar to the Company’s standard form of officer and director indemnification agreement, which is filed herewith as Exhibit 10.1.

Item 7.01. Regulation FD Disclosure.

On October 29, 2025, the Company issued a press release announcing the appointment of Mr. Roche to the Board. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated by reference herein.

The information (including Exhibit 99.1) being furnished pursuant to this Item 7.01 shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section and shall not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits
Exhibit Number			Description
10.1			Form of Indemnification Agreement
99.1			Press Release dated October 29, 2025
104			Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

			EMCOR Group, Inc.
Dated: October 29, 2025			By:			/s/ ANTHONY J. GUZZI
						Anthony J. Guzzi
						Chairman, President and
						Chief Executive Officer

FAQ

What did EMCOR Group (EME) announce in this 8-K?

EMCOR appointed Pat Roche to its Board of Directors, effective October 27, 2025.

What equity award did Pat Roche receive at EMCOR (EME)?

He received 158 restricted stock units, a prorated director grant.

What was the market value of the RSU grant to Pat Roche at EMCOR (EME)?

The grant had a market value of $119,266.30 based on the closing price on October 27, 2025.

How will Pat Roche be compensated as a director at EMCOR (EME)?

He will be compensated under EMCOR’s non‑employee director compensation policy as described in the 2025 Proxy Statement.

Did EMCOR (EME) enter into any agreement with Pat Roche?

Yes. He entered into the company’s standard indemnification agreement (Exhibit 10.1).

Was there a press release about the EMCOR (EME) board appointment?

Yes. A press release dated October 29, 2025 was furnished as Exhibit 99.1.